Table 2.
Treatment characteristics
| Type of surgery, n (%): | Pancreaticoduodenectomy (Whipple) | 17 (74) |
| Distal pancreatectomy | 2 (9) | |
| Other * | 4 (17) | |
| Resection status, n (%): | R2 | 8 (35) |
| R1 | 6 (26) | |
| R0 | 9 (39) | |
| IORT cone size, median cm (range) | 6.25 (5-10) | |
| R0-R2, mean (range) | 11.1 (6-15) | |
| IORT dose, Gy | R2, mean (range) | 12.1 (6-15) |
| R1, mean (range) | 11 (8-12) | |
| R0, mean (range) | 10.3 (8-12) | |
| Post-IORT Treatment: | External beam radiotherapy, n (%) | 11 (65) |
| XRT dose, mean, Gy (range) | 49 (45-54) | |
| Systemic therapy**, n (%) | 13 (76) | |
* - resection of recurrence (1), surgical bypass (roux-en-y) (2), cholecystecomy/gastrojejunostomy/choledochojejunostomy (1).
** - 5-fluorouracil +/- gemcitabine